|
Volumn 4, Issue 2, 2002, Pages 157-164
|
Clinical status and implications of antimalarial drug resistance
|
Author keywords
Drug resistance; Falciparum malaria
|
Indexed keywords
AMODIAQUINE;
ANTIMALARIAL AGENT;
ARTEETHER;
ARTEMETHER;
ARTEMISIN;
ARTESUNATE;
ATOVAQUONE;
BENFLUMETOL;
CHLOROQUINE;
CHLORPROGUANIL;
DAPSONE;
DIHYDROARTEMISININ;
DIHYDROFOLATE REDUCTASE;
FANSIDAR;
HALOFANTRINE;
MEFLOQUINE;
PROGUANIL;
AFRICA;
CLINICAL TRIAL;
DRUG COST;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SCREENING;
HUMAN;
MALARIA FALCIPARUM;
NONHUMAN;
PARASITE TRANSMISSION;
PLASMODIUM FALCIPARUM;
PRIORITY JOURNAL;
REVIEW;
AFRICA;
ANIMALS;
ANTIMALARIALS;
CULICIDAE;
DISEASE VECTORS;
DRUG RESISTANCE;
HEALTH POLICY;
HUMANS;
MALARIA;
NATIONAL HEALTH PROGRAMS;
PLASMODIUM FALCIPARUM;
WORLD HEALTH ORGANIZATION;
PLASMODIUM FALCIPARUM;
|
EID: 0036188537
PISSN: 12864579
EISSN: None
Source Type: Journal
DOI: 10.1016/S1286-4579(01)01523-4 Document Type: Review |
Times cited : (95)
|
References (31)
|